Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The weight loss and diabetes drug market is being reshaped by GLP-1-based therapies, led by Novo Nordisk's Ozempic Registered and Wegovy Registered and Eli Lilly's Mounjaro Registered (Zepbound for obesity)
Metformin derivatives - researchers' friends or foes
Cardiovascular : Stancic-Rokotov et al.: proteccin frente a infarto isqumico inducido en rata
GLP-1 receptor activated insulin secretion from pancreatic ss-cells: mechanism and glucose dependence
US$ 24.60
US$ 23.08
US$ 25.45
US$ 20.31
US$ 29.66
